Skip to main content
. 2023 Aug 18;15(8):e43732. doi: 10.7759/cureus.43732

Table 2. Distribution of prodromal symptoms and the duration of symptoms by gender.

A P-value of <0.05 was considered statistically significant. Data presented as N (%).

*Based on patients with prodromal symptoms

  Total (N) Gender P-value
Male Female
Total (N) 242 174 68 -
Prodromal symptoms 100 (41.3%) 64 (36.8%) 36 (52.9%) 0.022
*Symptom type
Chest pain (mild) 68 (68%) 47 (73.4%) 21 (58.3%) 0.120
Chest heaviness 44 (44%) 26 (40.6%) 18 (50%) 0.365
Chest burning 27 (27%) 16 (25%) 11 (30.6%) 0.548
Other types of pain 11 (11%) 7 (10.9%) 4 (11.1%) 0.979
Palpitation 42 (42%) 24 (37.5%) 18 (50%) 0.224
Unusual fatigue 23 (23%) 14 (21.9%) 9 (25%) 0.722
Sleep disturbance 22 (22%) 16 (25%) 6 (16.7%) 0.334
Shortness of breath 34 (34%) 23 (35.9%) 11 (30.6%) 0.586
Lightheadedness or dizziness 10 (10%) 5 (7.8%) 5 (13.9%) 0.331
Anxiety 23 (23%) 17 (26.6%) 6 (16.7%) 0.259
Sudden heat or flushing or a cold sweat 23 (23%) 15 (23.4%) 8 (22.2%) 0.890
Sudden back pain that is not related to an injury or exertion 22 (22%) 14 (21.9%) 8 (22.2%) 0.968
Sudden nausea or vomiting or unexplained indigestion 24 (24%) 18 (28.1%) 6 (16.7%) 0.198
*Duration of symptom
1 week 32 (32%) 19 (29.7%) 13 (36.1%) 0.679
2 weeks 26 (26%) 16 (25%) 10 (27.8%)
4 weeks 10 (10%) 8 (12.5%) 2 (5.6%)
More than a month 32 (32%) 21 (32.8%) 11 (30.6%)